Difference between revisions of "Ferric gluconate (Ferrlecit)"
Jump to navigation
Jump to search
m |
|||
Line 1: | Line 1: | ||
− | |||
− | |||
==General information== | ==General information== | ||
− | Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[ | + | Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[[Media:Ferricgluconate.pdf | Ferric gluconate (Ferrlecit) package insert (locally hosted backup)]]</ref><ref>[http://www.ferrlecit.com/default.aspx Ferrlecit manufacturer's website]</ref> |
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
Line 11: | Line 9: | ||
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/ferric-gluconate-patient-drug-information Ferric gluconate (Ferrlecit) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/ferric-gluconate-patient-drug-information Ferric gluconate (Ferrlecit) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/ferric-gluconate-patient-drug-information Ferric gluconate (Ferrlecit) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/ferric-gluconate-patient-drug-information Ferric gluconate (Ferrlecit) patient drug information (UpToDate)]</ref> | ||
+ | |||
+ | ==History of changes in FDA indication== | ||
+ | *2/18/1999: [http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20955ltr.pdf FDA approved] "for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy." | ||
+ | |||
+ | ==Also known as== | ||
+ | Sodium ferric gluconate complex in sucrose injection. | ||
==References== | ==References== | ||
Line 17: | Line 21: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
+ | [[Category:Iron]] | ||
[[Category:Drugs FDA approved in 1999]] | [[Category:Drugs FDA approved in 1999]] |
Revision as of 14:00, 26 November 2015
General information
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information
- 1 mL of Ferrlecit provides 12.5 mg of elemental iron
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
History of changes in FDA indication
- 2/18/1999: FDA approved "for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy."
Also known as
Sodium ferric gluconate complex in sucrose injection.